Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioanalysis|April 8, 2021
Whole blood stability evaluation of monoclonal antibody therapeutics using volumetric absorptive microsamplingHua Li, Maria Myzithras, Erica Bolella, et al.
Bioanalysis|November 22, 2018
Application of Mitra® microsampling for pharmacokinetic bioanalysis of monoclonal antibodies in ratsHua Li, Tammy Bigwarfe, Maria Myzithras, et al.
Mabs|September 7, 2016
Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeuticsMaria Myzithras, Tammy Bigwarfe, Hua Li, et al.
Bioanalysis|June 8, 2026
Preclinical pharmacokinetics of novel MYDGF for human PK and dose predictionMaria Myzithras, Wei Wei, Tammy Bigwarfe, et al.
Bioanalysis|February 17, 2018
Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflowMaria Myzithras, Tammy Bigwarfe, Erica Waltz, et al.
Bioanalysis|February 27, 2016
Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platformsMaria Myzithras, Hua Li, Tammy Bigwarfe, et al.
Mabs|August 2, 2022
Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeuticMaria Myzithras, Siqi Lin, Legairre Radden, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
Circulation Research|December 21, 2018
GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature DeathShavonn C Harper, Jaslyn Johnson, Giulia Borghetti, et al.
Circulation Research|September 19, 2015
GDF11 does not rescue aging-related pathological hypertrophyShavonn C Smith, Xiaoxiao Zhang, Xiaoying Zhang, et al.
Pageof 2